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Director:  R. Lee Franco, Ph.D.  
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Sympathetic overactivity (SO) is associated with obesity and cardiovascular disease 
(CVD) mortality.  Black adolescents have an increased risk of obesity and CVD later in 
life, particularly females.  PURPOSE:  To evaluate differences in SO between black 
(BOA) and white obese female adolescents (WOA).  METHODS:  Sixty-one BOA 
(n=49, 13.7±1.6 yrs, 38.1±6.1 kg/m
2
) and WOA (n=12, 13.3±2.2 yrs, 34.3±4.9 kg/m
2
) 
completed a maximal graded treadmill test after which an exercise recovery index (ERI; 
heart rate/VO2 plateau) was calculated.  RESULTS:  The ERI was significantly greater in 
BOA compared to WOA (29.8 ± 6.4 vs. 24.1 ± 3.1, P = 0.004). Multiple linear regression 
modeling revealed a significant independent association between ERI and VO2FFM (r = -
0.310, P = 0.027) and %FAT (r = 0.326, P = 0.020) in BOA only.  CONCLUSIONS:  
These results suggest that BOA females have greater SO than WOA females. 
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Review of Related Literature 
 
 
 
The metabolic syndrome (MetS), originally termed “syndrome X”, is a collection of 
interrelated metabolic factors that concomitantly raise an individual’s risk for developing 
coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM) (Reaven,1988). According to 
the National Cholesterol Education Program’s Adult Treatment Panel III (ATP III), MetS is 
identified when an individual expresses at least three of the following criteria: (1) Abdominal 
obesity defined by a waist circumference exceeding 102 or 88 cm for men and women, 
respectively, (2) Triglyceride levels greater than or equal to 150 mg/dL, (3) HDL cholesterol less 
than 40 or 50 mg/dL for men and women, respectively, (4) Blood pressure values greater than or 
equal to 130 mmHg systolic or 85 mmHg diastolic, and (5) Fasting plasma glucose levels greater 
than or equal to 110 mg/dL. Additionally, individuals taking anti-hypertensive or anti-diabetic 
medications are considered to have met the criteria for abnormal blood pressure or fasting 
plasma glucose, respectively (National Cholesterol Education Program [NCEP] Expert Panel on 
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment 
Panel III [ATP III], 2002).  
 A single consistent and objective set of criteria for appropriately diagnosing MetS in 
youth has not been officially accepted in the literature.  Several different MetS criteria have been 
employed for this population which typically involves the use of cut-points based on age- and 
gender-specific percentile values (Varda & Gregoric, 2009).  Perhaps the most commonly used 
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standards were established by Cook et al. in 2003 and define MetS in the child or adolescent 
when at least three of the following criteria are expressed:  (1) Abdominal obesity defined by a 
waist circumference greater than or equal to the 90
th
 percentile for age and gender, (2) 
Triglyceride levels greater than or equal to 110 mg/dl, (3) HDL cholesterol less than 40 mg/dl, 
(4) A systolic or diastolic blood pressure value greater than or equal to the 90
th
 percentile for age, 
height, and gender, and (5) Fasting plasma glucose levels greater than or equal to 100 mg/dl 
(Cook, Weitzman, Auinger, Nguyen, & Dietz, 2003).  Based on this definition, the prevalence 
for adolescent MetS in North America was most recently found to be 8.6% overall and 27.0% 
among obese adolescents.  As a subgroup of the population studied, males had higher prevalence 
rates when compared to females, 10.8% and 6.1%, respectively.  Furthermore, ethnicity impacts 
the prevalence of MetS with Hispanic and White adolescents having higher rates than Black 
adolescents, 11.2%, 8.9%, and 4.0%, respectively (Johnson, Kroon, Greenway, Bouchard, Ryan, 
& Katzmarzyk, 2009). 
The pediatric MetS definition mentioned above provides a useful tool for identifying 
individuals who display unfavorable risk factor profiles associated with the development of 
diseases in adulthood (Morrison, Friedman, Wang, & Gleuck, 2008).  A 25- to 30-year 
prospective follow-up of students participating in the Princeton Lipids Research Study revealed 
that pediatric MetS was an independent predictor of adult MetS and T2DM.  Furthermore, adult 
MetS was strongly associated with changes in age-specific BMI percentile, such that for every 
10-percentile unit change, the risk of adult MetS increased by 25.0% (Morrison, Friedman, 
Wang, & Gleuck, 2008).  An increase in the degree of insulin resistance (IR) has also been 
shown to increase the risk of developing MetS and the prevalence of each MetS component 
among obese children and adolescents (Juarez-Lopez, Klunder-Klunder, Medina-Bravo, 
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Madrigal-Azcarate, Mass-Diaz, & Flores-Huerta, 2010). Together these findings emphasize the 
central role of obesity and IR in this constellation of risk factors known as MetS.  Therefore, this 
review will focus on obesity and IR as central components in the development of MetS and their 
unique role in the disruption of the autonomic nervous system (ANS), often observed in those 
with CVD and T2DM. 
OBESITY  
The World Health Organization defines obesity as the accumulation of excess body fat 
resulting in an increased risk for metabolic and cardiovascular complications (World Health 
Organization Technical Consultation, 2000).  In 1998, the National Heart, Lung, and Blood 
Institute published clinical guidelines on the identification, evaluation, and treatment of 
overweight and obesity in adults (National Institutes of Health, National Heart, Lung, and Blood 
Institute, 1998). These guidelines included body mass index (BMI), a ratio of weight (kg) 
relative to height squared (m
2
), as a measure to quantify overweight and obesity through strong 
correlations with adiposity. Individuals are placed in 1 of 6 categories based on specified cut-off 
points representative of under-weight (<18.5 kg/ m
2
), normal-weight (18.5-24.9 kg/ m
2
), over-
weight (25.0-29.9 kg/ m
2
), or obese class I (30.0-34.9 kg/ m
2
), II (35.0-39.9 kg/ m
2
), or III (>40.0 
kg/ m
2
). In addition to BMI, waist circumference measurement (WC) is also suggested for the 
evaluation of disease risk. WC measures greater than 102 and 88 centimeters, for men and 
women respectively, place individuals at increased risk for developing obesity related CVD risk 
factors and morbidity (National Institutes of Health, National Heart, Lung, and Blood Institute, 
1998). 
In children and adolescents the BMI changes markedly with age and gender and therefore 
is typically considered as “BMI for age” values and interpreted using percentile cut-offs in 
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reference to the population (Must & Anderson, 2006).  Using age- and gender-specific BMI 
percentile values, children and adolescents are considered obese at or greater than the 95
th
 
percentile and considered overweight lower than the 95
th
 percentile but greater than or equal to 
the 85
th
 percentile (Krebs, Hines, Jacobson, Nicklas, Guilday, & Styne, 2007).  Waist 
circumference age-percentile scores based on population norms are an additional tool for the 
diagnosis of child and adolescent overweight and obesity (Reilly, 2010).  A recent systematic 
review showed similar accuracy for the BMI and waist circumference techniques in diagnosing 
obesity and risk for adverse cardiovascular risk factors (Reilly, Kelly, & Wilson, 2010). 
According to most recent prevalence estimates, 18.1% of U.S. adolescents ages 12-19 
years are considered obese based on BMI for age values.  Furthermore, ethnicity and gender play 
a role in the distribution of obesity across the population with black adolescent females having 
higher prevalence rates than white or Hispanic adolescent females, 29.2%, 14.5%, and 17.5%, 
respectively (Ogden, Carrol, Curtin, Lamb, & Flegal, 2010).  Obesity in this age group is 
associated with an increased risk for obesity and all-cause mortality in adulthood (McTigue, 
Garrett, & Popkin, 2002).  The ethnic differences seen in adolescent prevalence rates extends 
into adulthood as approximately 54.0% of U.S. black women and 30.0% of white women are 
considered obese (Ogden, Carroll, Curtin, McDowell, Tabak, & Flegal, 2006).  Together these 
findings suggest a racial divergence in the pathogenesis of obesity (Srinivasan, Myers, & 
Berenson, 2001). 
Pathophysiological mechanisms related to poor cardiovascular outcomes in adults are 
already operative in obese adolescents.  The degree of obesity in adolescence is a clinically 
relevant predictor of cardiovascular risk such that worsening BMI negatively effects the 
expression of each MetS component, namely IR (Weiss et al., 2004). The patterning of fat across 
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visceral and subcutaneous depots further describes these metabolic consequences such that 
adolescents with greater visceral accumulations express significantly higher IR, plasma 
triglyceride levels, and lower HDL concentrations (Taksali, 2008).  Ethnicity also plays a role in 
the expression of metabolic consequences associated with being obese.  A multi-ethnic study 
examining CVD risk profile in obese black and white female adolescents revealed that despite 
similar BMI, total body fat, and percent body fat, black subjects had nearly 30.0% less visceral 
adipose tissue than their white peers.  Interestingly, when these variations were related to 
metabolic parameters such as lipid profile and IR, a more atherogenic risk profile was observed 
in whites whereas blacks appear to display a more diabetogenic (insulin resistant) profile (Bacha, 
Saad, Gungor, Janosky, & Arslanian, 2003). 
INSULIN RESISTANCE  
Under normal conditions, beta cells of the human pancreas secrete the hormone insulin, 
which is responsible for regulating the metabolism of glucose, lipids, and proteins, as well as 
maintaining blood glucose concentrations (~ 80-90mg/100ml fasting state).  Insulin is released in 
response to the ingestion of high energy yielding meals and results in a shift from resting fatty 
acid utilization to the rapid uptake, storage, and use of glucose by all the tissues of the body, 
namely the liver, adipose tissue, and muscle cells.  These tissues convert any excess glucose into 
its storage form, glycogen, which can later be used for energy by the muscles when necessary. 
Between meals, when blood glucose concentrations begin to fall, insulin secretion is decreased 
and the stored liver glycogen is broken down to glucose and released into the blood stream 
(Guyton & Hall, pp. 961-965).  
The assessment of insulin action commonly employs measures that reflect the sensitivity 
of insulin to promote glucose uptake by the tissues and its subsequent metabolism.  Insulin 
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sensitivity can be assessed through direct and indirect methods, both of which measure the status 
of glucose metabolism in either stable or unstable circumstances (Matsuda, 2010).  To fully 
understand the mechanisms through which abnormalities in glucose handling cultivate, it is 
necessary to assess the action of multiple physiological variables, primarily, the pancreatic beta-
cell response to a given glucose load and the sensitivity of the tissues to insulin.  Because the 
processes involved in glucose homeostasis at both the tissue and beta-cell level occur 
simultaneously rather than in a specific sequence, an optimal measure of insulin resistance would 
involve in vivo methods to assess both beta-cell sensitivity to glucose and tissue sensitivity to 
insulin.  For this, the glucose clamp technique, proposed by DeFronzo and colleagues in 1979, 
provides a highly reproducible method (DeFronzo, Tobin, & Andres, 1979). 
The glucose clamp technique is considered the gold standard measure of insulin action 
(Ferrannini & Mari, 1998).  The clamp technique can be performed through two different 
versions, involving euglycemic or hyperglycemic methods as outlined by DeFronzo et al. 
(DeFronzo, Tobin, & Andres, 1979).  These methods provide reliable measures to quantify both 
beta-cell function and the sensitivity of insulin to act on its target tissues.  However, these 
methods present several disadvantages.  The requirement for two intravenous lines, calibrated 
pumps, and trained personnel make these techniques less practical for the widespread clinical 
diagnoses of IR.  For this reason, simpler methods are more practical for use outside of 
specialized research clinics (Ferrannini & Mari, 1998). 
The most common measure used to quantify whole body glucose tolerance in vivo is the 
oral glucose tolerance test (OGTT).  Aside from its use in quantifying glucose tolerance, the 
OGTT provides the ability to reflect the effectiveness of the beta-cells and the sensitivity of the 
tissues to insulin with reasonable accuracy when compared to the previously described clamping 
 7 
techniques (Stumvoll et al., 2000).  Generally, the OGTT is administered following an overnight 
fast of at least 10 hours, no less than three days of an unrestricted diet (>150 g of carbohydrate 
per day), and normal physical activity.  Fasting blood samples are drawn to measure plasma 
glucose and insulin concentrations after which the subject is asked to ingest a solution containing 
75g of glucose in 250-300 ml of water within a 5 minute time period.  Following the ingested 
glucose load, blood samples are taken every half hour for a total of 2 hours to assess plasma 
glucose and insulin levels (World Health Organization Expert Committee on Diabetes Mellitus, 
1980).  The blood glucose samples retrieved during an OGTT are used to stratify individuals into 
three categories of glucose tolerance based on 2-hour postload glucose values. Glucose values 
less than 140 mg/dl represent normal glucose tolerance, while any value between 140mg/dl and 
199 mg/dl represents impaired glucose tolerance. Blood glucose values greater than 200 mg/dl 
represent a provisional diagnosis of diabetes (American Diabetes Association, 2009). 
The homeostasis model assessment of insulin resistance (HOMA-IR) provides a simple 
and inexpensive alternative to the aforementioned techniques for assessing insulin sensitivity. 
HOMA-IR was developed in 1985 by Mathews et al. (Matthews, Hosker, Rudenski, Naylor, 
Treacher, & Turner, 1985) with the use of computer aided modeling of experimental human and 
animal data.  To compute HOMA-IR, a simple mathematical approximation is employed using 
the product of fasting insulin and glucose values [HOMA-IR = fasting plasma glucose (mmol/L) 
x fasting plasma insulin (µU/ml)/22.5] (Matthews, Hosker, Rudenski, Naylor, Treacher, & 
Turner, 1985).  The estimate of IR derived from HOMA-IR is significantly correlated to the 
gold-standard clamp techniques (Rs = 0.88, P < 0.0001) (Matthews, Hosker, Rudenski, Naylor, 
Treacher, & Turner, 1985), (Rs = 0.85, P < 0.0001) (Bonora et al., 2000).  
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The inability of insulin to stimulate its numerous functions, including the homeostasis of 
blood glucose, despite normal production and secretion of insulin by the pancreas, describes the 
pathological state of IR (Reaven, 1988).  In this compromised metabolic state, the beta cells of 
the pancreas are stimulated to secrete higher than normal concentrations of insulin in an attempt 
to maintain normal blood glucose levels.  The resulting compensatory hyperinsulinemic state is 
associated with glucose intolerance, increased plasma triglycerides, and decreased high-density 
lipoprotein cholesterol, all of which contribute to increased CHD mortality and overall 
cardiovascular risk (Fontbonne & Eschwege, 1991).  Furthermore, it is generally accepted that 
IR is a primary contributor toward the development of T2DM (DeFronzo, Bonadonna, & 
Ferrannini, 1992).  
The body’s attempt to compensate for IR triggers a cascade of events that are pivotal in 
the development of hypertension, T2DM, coronary artery disease, and MetS (Reaven, 1988).  In 
1988, these events led Dr. Gerald M. Reaven to first propose the suggestion that IR plays a 
primary role in the development of MetS (Reaven, 1988).  A general consensus now exists 
regarding the role of IR as a pathophysiological trait of MetS, however the central cause of IR is 
a highly debated topic (Savage, Petersen, & Shulman, 2005).  Although exact mechanisms 
remain to be established, IR is thought to originate primarily through a genetic abnormality or 
obesity (Mitchell et al., 1996).   
Differences in insulin secretion and sensitivity across ethnicities have been reported in 
healthy and obese adolescents.  In healthy adolescents, responses to a 2-hour hyperglycemic 
clamp were examined in 14 black and 16 white subjects.  First and second phase insulin 
concentrations were significantly higher in blacks compared to whites.  Additionally, an insulin 
sensitivity index was 35% lower in black adolescents compared with whites (P = 0.02) indicating 
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ethnic differences in insulin secretion and sensitivity early in life, even in healthy individuals 
(Arslanian, 1998).  Guitin et al., examined the role of fatness and fitness in describing the 
variation in fasting insulin concentrations amongst adolescents (Guitin, Yin, Humphries, 
Hoffman, Gower, & Barbeau, 2004).  Both cardiovascular fitness and percent body fat explained 
significant proportions of the variance in fasting insulin concentration with higher partial R
2
 
values for fatness (R
2
 = 0.33; P < 0.0001) than for fitness (R
2
 = 0.17; P < 0.0001).  In this group 
of adolescents, blacks displayed significantly higher fasting insulin values than whites, especially 
in females (Guitin, Yin, Humphries, Hoffman, Gower, & Barbeau, 2004). 
Regardless of age or gender, the degree of IR is associated with a higher prevalence of 
disorders related to each component of MetS in obese adolescents (Juarez-Lopez, Klunder-
Klunder, Medina-Bravo, Madrigal-Azcarate, Mass-Diaz, & Flores-Huerta, 2010).  Recent 
research has suggested a link between dysfunction of the ANS, obesity, and/or obesity-related 
disorders (Scherrer, Randlin, Tappy, Vollenweider, Jequier, & Nicod, 1994; Grassi et al., 1995).  
Altered ANS function, such as an attenuated parasympathetic nervous system (PNS) and/or an 
overactive sympathetic nervous system (SNS), has been demonstrated in patients with 
hypertension, MetS, obesity, and IR (Curtis & O’Keefe, 2002).  
THE AUTONOMIC NERVOUS SYSTEM  
The ANS is important in maintaining homeostasis of the human body and in performing 
various functions responsible for regulating the cardiovascular system in both healthy and 
diseased populations.  The primary task of the ANS involves conveying impulses from the 
central nervous system to peripheral organs.  The ANS is composed of two branches, the PNS 
and SNS.  Collectively these two branches work in synchrony to control HR, constriction and 
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dilation of blood vessels, contraction and relaxation of smooth muscle in a number of organs, 
and various glandular secretions (Freeman, Dewey, Hadley, Myers, & Froelicher, 2006). 
The PNS, known for its role during resting conditions, is primarily responsible for 
conserving energy by reducing HR and blood pressure.  This arm of the ANS is also known for 
facilitating digestion and absorption of nutrients (Freeman, Dewey, Hadley, Myers, & Froelicher, 
2006).  Approximately 75 percent of PNS innervation is supplied through the vagus nerve, which 
controls the entire thoracic and abdominal regions of the body including the heart, lungs, 
esophagus, stomach, liver, pancreas, and kidneys.  Virtually all of the terminal nerve endings of 
the PNS secrete the neurotransmitter acetylcholine (Ach).  Therefore, these PNS post-ganglionic 
neurons are termed cholinergic (Guyton, pp. 750-751). 
Opposing the actions of the PNS, the SNS prepares the body for challenges to survival 
(fight or flight) by a.) increasing HR, BP, and cardiac output, b.) diverting blood flow from the 
organs and skin to the skeletal muscles, c.) dilating the bronchioles in the lungs, and d.) reducing 
metabolic activity (Freeman, Dewey, Hadley, Myers, & Froelicher, 2006).  Nearly all of the 
sympathetic nerve endings respond to adrenal secretion of the neurotransmitters epinephrine (E) 
and norepinepherine (NE), otherwise known as adrenalin and noradrenalin, respectively. 
Because sympathetic responses are mediated through adrenalin and noradrenalin, SNS post-
ganglionic neurons are termed adrenergic (Guyton, p. 750-751).  
At rest, the sinoatrial (SA) node of the heart is responsible for controlling myocardial 
contraction rate.  The SA node is controlled by an intrinsic rate of spontaneous depolarization in 
the absence of influences from the ANS, referred to as the intrinsic HR (Jose & Collison, 1970). 
The intrinsic HR is approximately 100 beats per minute (bpm) in healthy humans and is 
dependent upon age, gender (Jose & Collison, 1970), and fitness status of an individual (Katona, 
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McLean, Dighton, & Guz, 1982).  SNS and PNS stimulation of the SA node predominates over 
the intrinsic HR such that PNS stimulation acts to slow HR whereas SNS activation accelerates 
HR (Scher, Ohm, Bumgarner, Boynton, & Young, 1972). 
The ANS regulates HR at the onset, during, and following dynamic exercise.  At the 
onset of exercise, HR increases rapidly followed by more gradual elevations in response to 
increasing workloads (Goldsmith, Bloomfield, & Rosenwinkel, 2000).  Maciel et al. evaluated 
the participation of both branches of the ANS within the initial HR response to dynamic exercise 
(Maciel, Gallo, Marin Neto, Lima Filho, & Martins, 1986).  PNS and SNS inhibition was 
achieved through intravenous administration of atropine and propranolol, respectively. 
Restriction of the PNS abolished the initial rapid increase in HR during the first 10 seconds.  
However, when the SNS was restricted there was no effect on HR during this same time period.  
During the slow phase of HR elevation, between 1 to 4 minutes of exercise, SNS restriction 
resulted in a significantly depressed HR response.  These results suggested that the rapid HR 
response to exercise is initially mediated by PNS withdrawal, up to approximately 100 beats per 
minute (bpm), and the latter more gradual HR response is managed by SNS stimulation, 
occurring at HR values greater than 100 bpm (Maciel, Gallo, Marin Neto, Lima Filho, & 
Martins, 1986).  
Autonomic control of HR during exercise has been shown to vary in response to the 
relative intensity of the exercise bout (Maciel, Gallo, Marin Neto, Lima Filho, & Martins, 1986).  
The acceleration of HR throughout exercise appears to occur in response to PNS withdrawal 
during relatively mild intensities (Robinson, Epstein, Beiser, & Braunwald, 1966).  However, 
heightened SNS activity becomes progressively more important as the intensity of exercise 
increases up to maximal levels (Robinson, Epstein, Beiser, & Braunwald, 1966).  Due to the 
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effects of progressive workload on autonomic stimulation, the intensity of an exercise bout will 
determine the speed at which HR returns to basal levels upon cessation of exercise (Savin, 
Davidson, & Haskell, 1982).  
Immediately following a dynamic exercise bout, HR decelerates exponentially toward 
resting values, a condition which is mediated through ANS control of the heart.  The time course 
and particular contributions of each branch of the ANS to HR deceleration during recovery from 
exercise has been assessed in athletes, patients with heart failure, and normal subjects (Imai et 
al., 1994).  Among athletes and normal subjects, there was a steep decline in HR during the first 
30 seconds of recovery followed by a more shallow decline throughout the remainder of the 2 
minute recovery period.  Upon administration of atropine for PNS blockade, the initial steep 
decline was abolished.  Based on these results the authors concluded that early heart rate 
recovery (HRR) is mediated by PNS reactivation (Imai et al., 1994).  Late HRR is said to be 
mediated by withdrawal of SNS stimulation, especially following high intensity exercise 
(Kannankeril, Le, Kadish, & Goldberger, 2004).  
ANS balance can be demonstrated by evaluating cardiopulmonary responses to various 
stimuli including plasma neurotransmitter concentrations, muscle sympathetic nerve activity, 
HR, heart rate variability (HRV), and HRR (Freeman, Dewey, Hadley, Myers, & Froelicher, 
2006).  All of these measures are strong predictors of cardiovascular risk and all-cause mortality 
(Lahiri, Kannankeril, & Goldberger, 2008).  However, no measure provides a valid assessment 
of ANS function under all conditions.  Therefore, when possible, it is advantageous to employ 
multiple techniques (Snitker, Macdonald, Ravussin, & Astrup, 2000).  
HRR provides important prognostic value to exercise testing.  Attenuated HRR following 
maximal exercise is an independent predictor of all-cause mortality in adults (Cole, Blackstone, 
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Pashkow, Snader, & Lauer, 1999).  Lin et al. tested this relationship in adolescents using HRR at 
1, 2, and 3 minutes post-exercise (1-, 2-, and 3-min HRR, respectively).  Significant inverse 
associations were observed between the HRR parameters and metabolic risk factors including 
waist circumference (P = 0.001 and <0.0001 for 2- and 3-min HRR, respectively), SBP (P = 
0.029 for 1-min HRR), and fasting glucose (P = 0.021 for 2-min HRR).     Additionally, the 
correlation between metabolic risk as a whole and 2- and 3-min HRR was significantly stronger 
in females than in males (Lin, Kuo, Lai, Lin, Tseng, & Hwang, 2008).   
Yeckel et al. recently introduced a novel exercise recovery index as a minimally invasive 
method to indirectly assess health status in respect to fitness, ANS control, and level of IR in at-
risk young individuals (Yeckel, Gulanski, Zgorski, Dziura, Parish, & Sherwin, 2009). By 
extending the HRR period from a maximal exercise test beyond the initial rapid PNS response (~ 
2 minutes), the investigators found the degree of heart rate recovery normalized for oxygen 
consumption (HR/VO2 plat) to provide a functional index of sympathetic activity. Furthermore, 
HR/VO2 plat was significantly associated with basal IR as well as stimulated whole-body insulin 
sensitivity affording this tool unique utility when exploring ANS function related to diseases 
associated with obesity and IR (Yeckel, Gulanski, Zgorski, Dziura, Parish, & Sherwin, 2009).  
Cardiovascular ANS function in adolescents has been explored in response to short-term 
evoked cardiovascular autonomic reactivity tests (Faulkner, Hathaway, & Tolley, 2003), urinary 
and plasma catecholamine levels (Wambach, Hossmann, Bonner, & Laaser, 1986), as well as 
short-term and 24-hour HRV recordings (Tanaka, Borres, Thulesius, Tamai, Ericson, & 
Lindblad, 2000).   Evidence suggests that healthy black adolescents display significantly higher 
cardiovascular ANS function, as compared to healthy white adolescents (Li et al., 2009; Gutin, 
Howe, Johnson, Humphries, Snieder, & Barbeau, 2005; Wang, Thayer, Treiber, & Snieder, 
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2005; Urbina, Bao, Pickoff, & Berenson, 1998).  In particular, Gutin et al. revealed more 
favorable ANS profiles in healthy black adolescents than in whites, despite higher SBP values in 
blacks.  Interestingly, the deleterious effects of poor body composition on ANS function were 
only significant in blacks, particularly females.  These findings suggest that as weight gain 
ensues, cardiac ANS function is compromised to a greater extent in black female adolescents 
than black male or white adolescents (Gutin, Howe, Johnson, Humphries, Snieder, & Barbeau, 
2005).  
ANS FUNCTION, INSULIN RESISTANCE & OBESITY IN ADOLESCENCE 
Abnormalities in SNS activity are often observed in individuals who express components 
of MetS, either individually or collectively. More specifically, attention has shifted toward the 
role of SNS activity in the development and progression of obesity, however whether abnormal 
SNS activity causes or is a consequence of obesity remains unresolved. Obesity is not an entirely 
homogenous disorder given that both SNS over- and under-activation have been documented in 
its presence (Snitker, Macdonald, Ravussin, & Astrup, 2000). Blunted SNS activity has been 
implicated in the genesis of obesity as a result of deficient thermogenesis eventually leading to a 
positive energy balance and thus weight gain (Bray, 1991). On the other hand, SNS 
overactivation, which specifically targets the heart, blood vessels, and kidneys, appears to 
exacerbate the metabolic consequences associated with obesity by predisposing individuals to 
the development of hypertension and other CVD risk factors (Davy & Hall, 2004).   
The relationship between ANS modulation and metabolic characteristics in obese 
children and adolescents has received increasing attention over the past decade.  As similarly 
observed in an adult population, equivocal data between the communicative exchange of the two 
ANS branches in obese adolescent individuals has revealed both over- (Riva et al., 2001; Rabbia 
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et al., 2003; Tascilar, Yokusoglu, Boyraz, Baysan, Koz, & Dundaroz, 2011) and under-activation 
(Yakinci, Mungen, Karabiber, Tayfun, & Evereklioglu, 2000; Vanderlei, Pastre, Junior, & 
Godoy, 2010; Dangardt, Volkmann, Chen, Osika, Marild, & Friberg, 2011) of the SNS.  The 
conflicting results could be related to the difficulty in controlling several variables in obese 
adolescents, such as IR, hypertension, and ethnicity (Nagai, Matsumoto, Kita, & Moritani, 2003).   
To describe the metabolic and ANS phenotype in adolescent obesity, Rabbone et al. 
examined the relationship between indices of insulin sensitivity and beta-cell function in relation 
to cardiac ANS regulation (Rabbone et al., 2009).  Eighteen female obese adolescents (12.7 ± 0.2 
years) and ten lean age- and gender-matched controls completed an OGTT for the estimation of 
insulin sensitivity and beta-cell function and 24-hour ECG Holter and ambulatory BP monitoring 
for the assessment of ANS function.  Adolescent obesity was characterized by ANS imbalance 
reflecting a significant reduction in PNS activation (P < 0.05) and subsequent elevation in SNS 
activation, which failed to reach significance.  PNS parameters were inversely related to insulin 
sensitivity indices (P < 0.05) but not with insulin secretion.  In accord with the relationship 
between ANS function and CVD risk factors such as IR, the evaluation of ANS pattern can be 
considered a useful tool in evaluating the early cardiovascular impact of weight gain in young 
populations (Rabbone et al., 2009).   
Cardiac ANS function and metabolic characteristics, namely IR, were evaluated in 32 
obese children (11.6 ± 2 years) and 30 age- and gender-matched control subjects (Tascilar, 
Yokusoglu, Boyraz, Baysan, Koz, & Dundaroz, 2011).  Time- and frequency-domain parameters 
of HRV were assessed using 24-hour ambulatory electrocardiographic recordings and level of IR 
was assessed with the HOMA-IR technique.  All HRV parameters, with the exception of SDNN, 
were significantly reduced (P <0.022) in obese children, reflecting PNS withdrawal and SNS 
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dominance.  Concerning metabolic status, the obese group had significantly higher insulin, 
triglycerides, vLDL-cholesterol, and lower HDL-cholesterol than controls.  Interestingly, when 
compared to their non-insulin-resistant counterparts, insulin-resistant obese children 
demonstrated markedly higher SNS dominance (P = 0.007) (Tascilar, Yokusoglu, Boyraz, 
Baysan, Koz, & Dundaroz, 2011).   
Kaufman et al. aimed to further elucidate the differences in ANS function between 
normal-weight (NW), overweight (OW), and obese (OB) children (11.5 ± 0.8 years) and the 
relationships between ANS function, leptin, and IR in each group (Kaufman, Kaiser, Steinberger, 
Kelly, & Dengel, 2007).  36 children (18 male, 18 female) were defined as NW, OW, or OB by 
an age-adjusted BMI score of less than the 85
th
 percentile, between the 85
th
 and 95
th
 percentiles, 
and greater than the 95
th
 percentile, respectively. OB children had significantly higher HRV 
markers of SNS activity (P = 0.001) and significantly lower PNS activity (P = 0.001).  No 
apparent differences were observed between OW and NW groups for either of the HRV 
measures of ANS function.  A significant positive association was observed between SNS 
dominance and IR (r = 0.34, P < 0.05).  This association vanished when adjusted for fat mass (r 
= -0.01, P = NS) suggesting a primary role of adiposity in this relationship (Kaufman, Kaiser, 
Steinberger, Kelly, & Dengel, 2007).   
In adults, obesity and hypertension are more common in blacks than in whites (Dustan, 
1990).  When considering gender with race, the prevalence of both obesity and hypertension is 
higher in black women than white women.  In men, no racial differences exist in obesity 
however black men display higher prevalence rates of hypertension when compared to white 
men (Liu et al., 1993).  SNS overactivity is a common hallmark of the obese state and thus has 
been implicated as a link between obesity and hypertension in black Americans (Eslami & Tuck, 
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2003).  To determine whether obesity causes SNS overactivity in black Americans Abate et al. 
recorded muscle sympathetic nerve discharge in 92 normotensive black men and women with a 
wide range of BMI (Abate et al., 2001).  In black women, overweight was closely correlated to 
SNS dominance (r = 0.45, P = 0.0009) whereas in black men SNS activity was dissociated from 
BMI (r = 0.03, P = NS) (Abate et al., 2001).  These ethnic and gender differences in SNS 
function were further supported by the same group of investigators who found that dietary-
induced weight loss expressed a significant positive effect on muscle SNS activity in black 
women (P = 0.03) but not in black men (Abbas et al., 2010). 
As detailed throughout this review, black individuals are at an increased risk of obesity, 
IR, and cardiovascular disease mortality during adulthood (Meadows et al., 2011).  Studies have 
shown ethnic differences in ANS function in healthy youth (Wang, Thayer, Treiber, & Sneider, 
2005) however to date, no studies have examined the effects of ethnicity on cardiovascular ANS 
function in obese adolescents.  Therefore the primary aim of this study is to explore the 
relationship between ethnicity and SNS function, assessed with the exercise recovery index 
proposed by Yeckel et al., in an obese adolescent population.  Additionally, relationships 
between several variables known to affect ANS control in this population, namely cardiovascular 
fitness, level of obesity, IR, gender, and duration of obesity will be explored.  Cardiovascular 
health/fitness outcomes, including maximal HR and maximal oxygen consumption will be 
measured during a graded exercise test on a treadmill to volitional fatigue.  Additionally, SBP, 
both at rest and in response to a graded exercise test will be measured.  To assess SNS activity, 
HR and VO2 will be collected simultaneously every 30 seconds during a five-minute passive 
recovery period.  Fasting blood samples will be taken to assess insulin sensitivity through the 
HOMA-IR technique.  Anthropometric measures will include BMI-for-age percentile values, 
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waist and hip circumference-for-age percentile values, and lastly dual-energy x-ray 
absorptiometry will be used to measure regional adiposity.  
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SPECIFIC AIMS 
 
SA1: The primary aim of this study is to evaluate racial differences in SNS activity, assessed 
with an exercise recovery index, in obese female adolescents.    
 
SA2: A secondary aim is to assess the extent to which several variables known to affect ANS 
control, namely cardiovascular fitness, level of obesity, IR, and duration of obesity, help explain 
the variance among autonomic nervous system function in obese adolescent females of different 
ethnicities.   
 
RESEARCH STRATEGY 
 
Significance 
 The metabolic syndrome (MetS), originally termed “syndrome X”, is a collection of 
interrelated metabolic factors that concomitantly raise an individual’s risk for developing 
coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM) (1).  MetS in the child or 
adolescent is defined when at least three of the following criteria are expressed:  1). Abdominal 
obesity defined by a waist circumference greater than or equal to the 90
th
 percentile for age and 
gender, 2). Triglyceride levels greater than or equal to 110 mg/dl, 3). HDL cholesterol less than 
40 mg/dl, 4). A systolic or diastolic blood pressure value greater than or equal to the 90
th
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percentile for age, height, and gender, and 5). Fasting plasma glucose levels greater than or equal 
to 100 mg/dl (2).  Based on this definition, the prevalence for adolescent MetS in North America 
was most recently found to be 8.6% overall and 27.0% among obese adolescents (3).  An 
increase in adiposity and the degree of insulin resistance (IR) have been shown to increase the 
risk of developing MetS among obese children and adolescents emphasizing the central role of 
obesity and IR in this constellation of risk factors (4). 
The World Health Organization defines obesity as the accumulation of excess body fat 
resulting in an increased risk for metabolic and cardiovascular complications (5).  Body mass 
index (BMI), a ratio of weight (kg) relative to height squared (m
2
), is a measure commonly used 
to quantify overweight and obesity through strong correlations with adiposity (6).  In children 
and adolescents the BMI changes markedly with age and gender and therefore is typically 
considered as “BMI for age” percentile values in reference to the population (7). According to 
most recent prevalence estimates, 18.1% of U.S. adolescents ages 12-19 years are considered 
obese, having BMI for age values ≥ 95th percentile.  Furthermore, in females, the impact of 
ethnicity plays a role in the distribution of obesity with black adolescents having higher 
prevalence rates than white or Hispanic adolescents, 29.2%, 14.5%, and 17.5%, respectively (8).  
These ethnic differences extend into adulthood as approximately 54.0% of U.S. black women 
compared to 30.0% of white women are considered obese (9).   
 It has been suggested that white adolescents demonstrate a more atherogenic risk profile 
whereas black adolescents appear to display a more diabetogenic (insulin resistant) profile (10).  
The inability of insulin to stimulate its numerous functions, including the homeostasis of blood 
glucose, despite normal production and secretion of insulin by the pancreas, describes the 
pathological state of IR.  The body’s attempt to compensate for IR triggers a cascade of events 
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that are pivotal in the development of hypertension, T2DM, coronary artery disease, and MetS 
(1).  Significant differences have been observed across ethnicities in analysis of insulin secretion 
and sensitivity in both healthy and obese adolescents.  Black subjects, as compared to white 
subjects, have shown significantly lower sensitivity (11) and significantly higher fasting insulin 
concentrations (12).  Regardless of age and gender, the degree of IR is often associated with a 
higher prevalence of disorders related to each component of MetS in obese adolescents (4). 
Recent research has suggested a link between dysfunction of the autonomic nervous system 
(ANS) and factors common to MetS, namely obesity and IR (13,14).   
Black adolescents have an increased risk of obesity, IR, and cardiovascular disease 
mortality later in life (15).  Additionally, current evidence suggests that healthy black 
adolescents display higher cardiovascular ANS reactivity than healthy white adolescents (16-19).  
A study performed by Gutin et al. revealed that the deleterious effects of poor body composition 
on ANS function were only significant in blacks, particularly females, suggesting that as weight 
gain ensues, cardiac ANS function is compromised to a greater extent in black female 
adolescents than black male or white adolescents (17).  The relationship between ANS 
modulation and metabolic characteristics in obese children and adolescents has received an 
increase in attention over the past decade.  In agreement with observations reported in adults, 
differing data describing the interplay between the two branches of the ANS in obese adolescents 
has been observed, revealing both over- (20-22) and under-activation (23-25) of the SNS.  The 
conflicting results could be related to the difficulty in controlling several variables when 
measuring ANS function in this population, such as metabolic profile and ethnicity (26).   
Cardiopulmonary responses to evoked cardiovascular reactivity tests, such as exercise 
testing, can be used to demonstrate ANS balance through evaluations of plasma neurotransmitter 
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concentrations, muscle sympathetic nerve activity, heart rate, blood pressure, heart rate 
variability (HRV), and HRR (27).  Yeckel et al. recently introduced a novel exercise recovery 
index as a minimally invasive method to indirectly assess health status in respect to fitness, SNS 
control, and level of IR in at-risk young individuals (28). By extending the HRR period from a 
maximal exercise test beyond the initial rapid PNS response (~ 2 minutes), the investigators 
found the degree of heart rate recovery normalized for oxygen consumption (HR/VO2 plat) to 
provide a functional index of sympathetic activity. Furthermore, HR/VO2 plat was significantly 
associated with basal IR as well as stimulated whole-body insulin sensitivity affording this tool 
unique utility when exploring ANS function related to diseases associated with obesity and IR 
(28). 
To date, no studies have examined the effects of ethnicity on cardiovascular ANS 
function in obese adolescents.  Discovering ethnic differences in ANS modulation and the 
relationships between the metabolic consequences of obesity distinct to each race could offer 
valuable insight for treatment and prevention strategies in these at-risk obese adolescents.  
 
APPROACH 
 
Subjects.  Seventy-five obese white and black adolescent females (BMI ≥95th percentile for age 
and gender) will be recruited from the VCU TEENS program to participate in this study.  Only 
individuals cleared for participation in exercise testing by the TEENS physicians will be 
recruited.  All participants will perform a graded maximal exercise test on a treadmill to 
exhaustion and undergo blood sampling for metabolic testing.  Subjects who have been 
diagnosed with any known form of cardiovascular disease or diabetes, taking any medications 
known to affect insulin action or autonomic function, or have any orthopedic problems limiting 
the ability to complete the exercise test will be excluded from the study.  All subjects and 
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parents/legal guardians will be familiarized with procedures and subsequently asked to sign 
consent and assent forms, respectively.   
Graded Exercise Test.  Subjects will perform a progressive maximal treadmill walking test until 
volitional fatigue.  Resting hear rate and blood pressure will be measured prior to testing.  The 
treadmill protocol will consist of a 4 minute warm up at 2.5 MPH at 0% grade followed by a 2 
minute stage at 3.0 MPH at 0% grade.  Subsequent 2 minute stages will be held at 3.0 MPH and 
grade will be increased by 2.5% every 2 minutes until the subject is no longer able to maintain 
the treadmill pace.  Heart rate will be obtained at the end of every minute utilizing a heart rate 
monitor.  Blood pressure and ratings of perceived exertion (6-20 Borg Scale) will be obtained at 
the end of every stage.  Continuous breath by breath measurement of VO2 (L/min
-1
 & ml/kg/min
-
1
), VCO2 (L/min
-1
), respiratory rate (breaths per minute), and RER (VCO2/VO2) will be obtained 
during the exercise test.  
Assessment of Autonomic Function.  Following attainment of VO2peak, subjects will stop pedaling 
and passively cool down for 5 minutes while seated on the cycle ergometer.  To assess 
parasympathetic nervous system activity, the decline in heart rate recovery at 1 and 2 minutes 
post-exercise will be evaluated. To assess sympathetic nervous system activity, HR and oxygen 
consumption (VO2) will be recorded simultaneously every 30 seconds during the five-minute 
passive recovery period.  The value representing the time point during recovery where the ratio 
of heart rate recovery to oxygen consumption (HR/VO2) initially reaches a plateau will represent 
a functional index of sympathetic activity. 
Insulin Resistance/Sensitivity. As part of their enrollment into the TEENS program, participants 
will have resting glucose and insulin values measured, as well as complete an oral glucose 
tolerance test.  To compute the Homeostasis Model Assessment of Insulin Resistance (HOMA-
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IR), a simple mathematical approximation will be employed using the product of fasting insulin 
and glucose values (HOMA-IR = [(fasting plasma glucose x fasting plasma insulin)/22.5]).  The 
composite Whole Body Insulin Sensitivity Index (WBISI) is based on values of insulin and 
glucose obtained from the OGTT (WBISI = [10,000/√((fasting glucose x fasting insulin)(mean 
glucose x mean insulin))]).      
Body Composition Assessment.  Body composition will be assessed with dual-energy x-ray 
absorptiometry (DXA).  The DXA will provide a measure of fat mass, fat-free mass and percent 
body fat.  Additionally, abdominal girth will be measured at the level of the umbilicus. Waist 
circumference will be measured at the narrowest point on the torso.  Hip circumference will be 
measured at the maximal circumference of the buttocks.  Waist-to-Hip ratio will be used to help 
determine the degree of abdominal obesity.  All measures are made using an anthropometric 
tape.  Height will be assessed with a stadiometer (cm) and body mass (kg) will be determined 
with a medical scale.  Body mass index (kg/ m
2
) will be calculated by dividing weight (kg) by 
height squared (m
2
). 
Statistical Analyses.  An analysis of variance will be performed to determine significant 
differences between groups.  Multiple linear regression modeling will be used in order to 
determine relationships between the exercise recovery index with cardiorespiratory fitness, 
anthropometric measures, insulin resistance, gender, and duration of obesity.   
 
PREMILINARY STUDIES 
 
Reductions in Functional Sympathetic Overactivity in Obese Adolescents Following a Weight 
Management Program 
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Abstract 
Sympathetic overactivity (SO) is associated with several disease states including type 2 diabetes 
and obesity.  PURPOSE:  To evaluate the association of SO, as assessed by an exercise recovery 
index (ERI; heart rate/VO2 plateau), with insulin resistance (HOMA-IR), cardiovascular fitness 
(VO2peak), and percent body fat (%FAT) in obese adolescents participating in a three month 
weight management program.  METHODS:  Forty participants (13.7±1.6 yrs.; Body Mass 
Index, 36.9±6.5 kg/m2) volunteered to participate in this study.  % FAT, VO2peak, ERI, 
HOMA-IR were assessed at enrollment and after 3-months of program participation.  Program 
components included physical activity, nutrition education, and behavioral support.  RESULTS:  
Using multiple linear regression modeling, there was a significant independent association 
between ERI and %FAT (r = 0.539, p < 0.000) after controlling for both VO2peak per lean tissue 
and HOMA-IR.  However, VO2peak per lean tissue (r = -0.306, p = 0.061) and HOMA-IR (r = 
0.052, p = 0.755) were not independently associated with ERI.  ERI (n = 23; 29.1±7.1 vs. 
25.1±7.6, p = 0.027) and VO2peak per lean tissue (n = 23; 47.2±7.5 vs. 50.6±8.2, p = 0.023) 
were significantly reduced after the program.  %FAT and HOMA-IR remained unchanged.  
CONCLUSIONS:  These results suggest that insulin resistance is distinct and not impacted by 
SO in young overweight adolescents.  Additionally, involvement in a weight management 
program may attenuate the development of pathological risk factors associated with SO.  
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Examining Racial Differences in Sympathetic Activity Assessed During Recovery from Exercise 
in Obese Adolescent Females 
 
 
 
INTRODUCTION 
 
Adolescent obesity has been increasing at alarming rates over the past three decades with 
most recent prevalence estimates classifying 18.1% of U.S. adolescents as obese (Body Mass 
Index [BMI] > 95th percentile for age and gender) (Ogden, Carrol, Curtin, Lamb, & Flegal, 
2010).  This rise in adolescent obesity has led to an equally alarming 8.6% prevalence of 
adolescent metabolic syndrome (MetS), a clustering of metabolic abnormalities that tend to 
originate from obesity (Johnson, Kroon, Greenway, Bouchard, Ryan, & Katzmarzyk, 2009).  
MetS, which includes impaired glucose tolerance, hypertension, elevated triglyceride and LDL 
cholesterol, and low HDL cholesterol, significantly increases the risk of all-cause morbidity and 
mortality later in life (Morrison, Friedman, Wang, & Gleuck, 2008).  Furthermore, the presence 
of obesity and MetS during adolescence elevates the risk for several adverse clinical outcomes 
including early onset of atherosclerosis, insulin resistance, type II diabetes mellitus, obstructive 
sleep apnea, and psychological depression (Raj & Kumar, 2010).   
A common detriment of obesity and MetS is cardiovascular autonomic nervous system 
(ANS) dysfunction (Snitker, Macdonald, Ravussin, & Astrup, 2000).  In healthy individuals, the 
primary task of the ANS involves balancing impulses from the central nervous system to 
peripheral organs via two branches, the parasympathetic nervous system (PNS) and the 
sympathetic nervous system (SNS) (Freeman, Dewey, Hadley, Myers, & Froelicher, 2006).  In 
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obese populations, disequilibrium of the ANS is reflected by reduced PNS function and/or SNS 
overactivity (SO).  Over-activation of the SNS specifically targeting the heart, blood vessels, and 
kidneys appears to exacerbate the metabolic consequences associated with obesity by 
predisposing individuals to the development of hypertension and other cardiovascular disease 
(CVD) risk factors (Davy & Hall, 2004).   
The relationship encompassing SNS activity, obesity, and a poor metabolic profile has 
been studied extensively in obese adults (Scherrer, Randlin, Tappy, Vollenweider, Jequier, & 
Nicod, 1994; Grassi et al., 1995; Davy & Orr, 2009).  However, in obese children and 
adolescents, this topic has only recently received attention (Guizar, Ahuatzin, Amador, Sanchez, 
& Romer, 2005).  As similarly observed in adults, equivocal data regarding the impact of obesity 
on SNS function, measured with heart rate variability (HRV), during adolescence has revealed 
both over- (Riva et al., 2001; Rabbia et al., 2003; Tascilar, Yokusoglu, Boyraz, Baysan, Koz, & 
Dundaroz, 2011) and under-activation (Vanderlei, Pastre, Junior, & Godoy, 2010).  These 
conflicting results could be related to the difficulty in controlling several variables in this 
population, such as ethnicity and gender (Nagai, Matsumoto, Kita, & Moritani, 2003).   
Black female adolescents have an increased risk of obesity, IR, and cardiovascular 
disease mortality later in life (Srinivasan, Myers, & Berenson, 2001). Current evidence suggests 
that normal weight black adolescents display a more effective cardiovascular ANS reactivity, 
marked at rest by high PNS and low SNS function, than white adolescents (Li et al., 2009; Gutin, 
Howe, Johnson, Humphries, Snieder, & Barbeau, 2005; Wang, Thayer, Treiber, & Snieder, 
2005; Urbina, Bao, Pickoff, & Berenson, 1998).  Interestingly, in a bi-racial group of healthy 
male and female adolescents, the detrimental effects of higher levels of adiposity on ANS 
function impacted black females to a greater extent, this was marked by reduced PNS activity 
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and elevated SNS activity.  The findings of this cross-sectional study may suggest that poor body 
composition negatively affects cardiac ANS function to a greater extent in black female 
adolescents than black male or white adolescents (Gutin, Howe, Johnson, Humphries, Snieder, & 
Barbeau, 2005).   
Adolescent cardiovascular ANS function has been explored in response to short-term 
evoked cardiovascular autonomic reactivity tests (Faulkner, Hathaway, & Tolley, 2003), urinary 
and plasma catecholamine levels (Wambach, Hossmann, Bonner, & Laaser, 1986), as well as 
short-term and 24-hour HRV recordings (Tanaka, Borres, Thulesius, Tamai, Ericson, & 
Lindblad, 2000).   A novel exercise recovery index (ERI) was recently introduced as a minimally 
invasive method to indirectly assess SNS control in at-risk young individuals (Yeckel, Gulanski, 
Zgorski, Dziura, Parish, & Sherwin, 2009).  By extending the recovery period from a maximal 
exercise test beyond the initial rapid PNS response (~ 2 minutes), the ratio taken during the time-
point into recovery where the degree of heart rate recovery normalized for oxygen consumption 
(HR/VO2 plateau) initially plateaus defines the ERI value for that individual.  Normalizing the 
HR for the prevailing VO2 within the ERI allows for the adjustment of absolute exercise 
intensity and the requirement for early excess post-exercise oxygen consumption.  Individuals 
with lower stroke volume require high HR to sustain the prevailing oxygen consumption and 
would thus have higher SNS activation to achieve the higher HR during recovery.  This ERI was 
shown to provide a functional index of SNS activity.  
To date, no studies have directly examined the effect of ethnicity on SNS function in 
obese adolescents.  Therefore, the primary aim of this study is to explore the relationship 
between ethnicity and SNS function in obese adolescent females, assessed with the simple 
HR/VO2 plat exercise recovery index (ERI).  It is hypothesized that SNS activity, as measured 
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by the ERI, will be higher in black obese adolescent females than white obese adolescent 
females.   
METHODS 
Subjects 
 
Obese female adolescents were recruited to participate in this study.  Subjects were 
participants of the Virginia Commonwealth University (VCU) T.E.E.N.S. Program, a healthy 
weight management program administered by the Departments of Pediatrics, Health and Human 
Performance, and Psychology.  Upon enrollment in the program, participants received a 
comprehensive medical, physical and psychosocial evaluation.  Participants were cleared for 
participation in exercise testing by the T.E.E.N.S. physicians.  Individuals diagnosed with any 
known cardiovascular or metabolic disorders (e.g., diabetes and obstructive sleep apnea (OBSA)) 
or taking medications that could potentially influence cardiovascular or endocrine function were 
excluded from the study (e.g., Thyroxine, Levothyroxine, Metformin, and Melatonin).  All risks 
and benefits associated with the study procedures were explained and written consent/assent was 
obtained.  This study was approved by the VCU Institutional Review Board and no costs were 
incurred by participants or their families. All reported measures were obtained prior to beginning 
the program (baseline). 
Procedures 
 
 During each participant's medical visit, anthropometric measures were assessed and a 
resting blood sample was obtained from an antecubital vein between 8 and 10 hours after an 
overnight fast for assessment of total cholesterol (TC), triglycerides (TAG), low-density 
lipoprotein (LDL), high-density lipoprotein (HDL), glucose, and insulin. The comprehensive 
metabolic panel and lipid profile assays were performed in the main clinical laboratory at VCU 
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Health System.  Subjects were scheduled within one week for a maximal exercise test and 
informed to report to the Human Performance Laboratory at least 4 hours postprandial.      
Insulin Resistance/Sensitivity 
To compute the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), a 
simple mathematical approximation was employed using the product of fasting insulin and 
glucose values (HOMA-IR = [(fasting plasma glucose x fasting plasma insulin)/22.5]).  The 
glucose and insulin values from the oral glucose tolerance test were performed at the Clinical 
Research Center (CRC) core laboratory.      
Body Composition Assessment  
Weight (kg) was assessed with a digital medical scale and height (cm) with a stadiometer.  
Body Mass Index (BMI) was then calculated (kg/m
2
).  Total body composition was measured 
with bioelectrical impedance analysis (BIA, Quantum II, RJL Systems).  BIA was used to 
provide percent fat (%FAT) and fat-free mass (FFM).   
Treadmill Graded Exercise Test  
Cardiovascular fitness (CVF) was assessed using a progressive walking protocol 
designed to elicit maximal effort (VO2peak) on a treadmill (TrackmasterTMX425C, Full Vision, 
Inc., Newton, KS).  The treadmill protocol consisted of a 4-minute warm up at 2.5 MPH at 0% 
grade followed by a 2-minute stage at 3.0 MPH at 0% grade and a subsequent 2-minute stage at 
3.0 MPH at 2.0% grade.  Subsequent 2-minute stages were held at 3.0 MPH with the grade 
increasing by 3.0% each stage until volitional fatigue was attained.  Heart rate (HR) was 
obtained at the end of every minute utilizing a heart rate monitor (Model E600, Polar electro, 
Kempele, Finland).  Blood pressure and ratings of perceived exertion (6-20 Borg Scale) were 
obtained at the end of every stage.  Continuous breath-by-breath measurement (Vmax Encore 29 
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System, VIASYS Healthcare Inc, Yorba Linda, CA) of VO2 (L/min
-1
 & ml/kg/min
-1
), and RER 
(VCO2/VO2) were obtained throughout the exercise test.  Following attainment of VO2peak, 
maximal oxygen consumption per FFM (VO2FFM) was calculated by dividing absolute VO2 
(ml/min) by kilograms of FFM.  
Assessment of Autonomic Function  
 
Immediately following attainment of VO2peak, subjects completed a 5-minute passive 
cool-down while standing as still as possible with their hands by their sides.  During the 5-
minute recovery period, HR was recorded every 30 seconds and VO2 was recorded continuously.  
The decline in heart rate recovery at 2-minutes post-exercise (HRR-2) was used to evaluate PNS 
activity.  To assess SNS activity, the ratio of HR (bpm) to VO2 (ml·kg
-1
·min
-1
, 10 second 
averages) (HR/VO2) was calculated for every 30-second interval and graphed against each 
respective time point using Microsoft Excel.  The HR/VO2 value representing the time point 
during recovery where the ratio initially reached a plateau was termed ERI and taken as a 
functional index of sympathetic activity (Yeckel, Gulanski, Zgorski, Dziura, Parish, & Sherwin, 
2009). 
Statistical Analyses 
 A one-way ANOVA (SPSS, Chicago, IL: V19.0) was used to compare subject 
demographics between the two groups.  Simple associations between ERI and health 
characteristics were evaluated using Pearson product-moment correlations.  Multiple linear 
regression was performed to assess the independent variability of ERI with %FAT, HOMA-IR, 
fasting insulin, fasting TAG, VO2FFM, and SBP.  Log transformations of the insulin sensitivity 
indices were used to satisfy assumptions of the statistical methods.  All data are expressed as 
mean ± SD unless otherwise noted. 
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RESULTS 
 Sixty-one adolescents participated in the study (Black: N= 49; White: N= 12).  Subject 
characteristics for both black and white females are presented in Table 1.  Resting insulin 
concentrations were unable to be determined in two of the black females.  Therefore, the black 
obese female group had 47 subjects for all fasting insulin and HOMA-IR data analyses.  There 
were no significant differences with regard to age or BMI between the two groups (P = 0.506 
and P = 0.119, respectively).  Black females had significantly higher ERI values than white 
females (29.8 ± 6.4 vs. 24.1 ± 3.1; P = 0.004) as displayed in Figure 1.  Additionally, the black 
females displayed significantly higher SBP values (P = 0.012) and lower fasting TAG 
concentrations (P = 0.001) than the white females.   
 Pearson product-moment correlations between ERI and health variables in both black and 
white females are presented in Table 2.  A significant relationship between ERI and VO2FFM was 
present in only the obese black females (Figure 2).  Percent fat approached, but failed to reach 
significance with ERI (r = 0.275, P = 0.056).  No significant relationships were observed in the 
white females between ERI and the health variables (P ≥ 0.374).   
A multiple linear regression analysis was performed to determine relative contributions 
of various health characteristics to ERI, as displayed in Table 3.  The dependent variable tested 
for each group was ERI.  The independent variables tested were %FAT, HOMA-IR, fasting 
insulin, fasting TAG, VO2FFM, and SBP.  In the black females, 27.0% (P = 0.037) of the ERI 
variance was explained for by the independent variables with significant contributions from 
%FAT (10.0%) and VO2FFM (9.6%).  White females had 37.5% (P = 0.788) of the variance 
explained, however none of the independent variables provided a significant contribution.  
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Additionally, semi-partial correlations, presented in Table 3, describe the unique contribution to 
explaining the dependent variable when variance was controlled.   
DISCUSSION 
To our knowledge, this is the first study to examine the effects of ethnicity on SNS 
function in obese adolescent females.  The major finding of this study was that black obese 
adolescent females display higher SNS activity than their white counterparts as indexed by the 
ERI.  Overactivation of the SNS is a common hallmark of the obese state and thus has been 
implicated as a link between excess adiposity and cardiovascular disease risk (Raj, 2012), 
especially in black individuals (Eslami & Tuck, 2003).  As suggested in the current study, 
pathophysiological mechanisms related to poor cardiovascular outcomes in adults are already 
operative in obese adolescents.  In the United States, adolescent obesity is more common in 
black individuals than in white, particularly black females (Liu et al., 1993; Ogden, Carrol, 
Curtin, Lamb, & Flegal, 2010).  Various studies have shown ethnic differences in ANS function 
in adult (Abate et al., 2001; Abbas et al., 2010; Weyer, Pratley, Snitker, Spraul, Ravussin, & 
Tatarami, 2000; Choi et al., 2006) and healthy youth (Wang, Thayer, Treiber, & Sneider, 2005; 
Guitin, 2005) populations.  However, little is known in regards to ANS function and ethnic 
differences in obese adolescents.  
Much of the evidence evaluating ethnic differences in ANS function in healthy 
adolescents indicates that black individuals display more favorable resting HRV profiles than 
white individuals (Liao, Barnes, Chambless, Simpson, Sorlie, & Heiss, 1995; Urbina, Bao, 
Pickoff, & Berenson, 1998; Wang, Thayer, Treiber, & Snieder, 2005).  Studies exploring gender 
differences in resting HRV have revealed equivocal results (Evans et al., 2001; Koskinen et al., 
2009; Umetani, Singer, McCraty, Atkinson, 1998; Bomemeier et al., 2003).  Few studies have 
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directly evaluated the effects of ethnicity on ANS function in females.  In line with the present 
findings, Gonzalez-Trapega et al. (2000) uncovered ethnic differences in SNS activity in a 
diverse sample of black and white, male and female adults.  Basal plasma epinephrine (E) levels 
were measured to assess SNS function.  No differences in plasma E levels were found between 
white males or black males and black females.  However, plasma E levels were significantly 
higher in black females than in white, suggesting that black females display elevated SNS 
activity at rest when compared to white females.  The results within the current study support the 
ERI as a potential tool in assessing SO and the disproportionately high risk of obesity, IR, and 
CVD mortality later in life of black adolescent females (Srinivasan, Myers, & Berenson, 2001).   
The cross-sectional data of the current study revealed a significant inverse relationship 
between ERI and VO2FFM in the black females only.  Gutin et al. (2005) revealed similar findings 
associated with impaired ANS function in their bi-racial group of 304 non-obese male and 
female adolescents.  Subjects completed a graded treadmill test to exhaustion for the assessment 
of CVF and ANS balance was calculated from HRV.  With gender combined, the black 
adolescents expressed more favorable HRV profiles, marked by higher PNS activity, than the 
white adolescents.  Higher CVF was significantly associated with more favorable PNS function 
in black females but was not significantly related to PNS activity in males or white females.  
Interestingly, when the effects of body composition on ANS function were analyzed, reduced 
PNS activity coupled with an increase in SNS activity was revealed.  These deleterious effects of 
increasing adiposity on ANS control were only significant in the black adolescents, particularly 
females.  Supporting the present implications in obese adolescents, these findings may suggest 
that as weight gain ensues and CVF deteriorates, cardiac ANS function is compromised to a 
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greater extent in black female adolescents than black male or white adolescents (Gutin, Howe, 
Johnson, Humphries, Snieder, & Barbeau, 2005).   
Autonomic function in adolescence has been shown to be mediated by several metabolic 
factors including body composition (Li et al., 2009), IR (Tascilar, Yokusoglu, Boyraz, Baysan, 
Koz, & Dundaroz, 2011), leptin (Kaufman, Kaiser, Steinberger, Kelly, & Dengel, 2007), SBP 
(Guizar, Ahuatzin, Amador, Sanchez, & Romer, 2005) and CVF (Gutin, Howe, Johnson, 
Humphries, Snieder, & Barbeau, 2005).  Given the previous evidence describing these 
relationships, we used multiple regression to adjust for potential covariates of ERI including 
%FAT, HOMA-IR, fasting insulin, fasting TAG, VO2FFM, and SBP.  The results of the present 
study suggest that only %FAT and VO2FFM were able to explain a significant independent portion 
of the ERI in the black females.  The implications of our findings agree with a previous study 
performed in a bi-racial adult population.  Abate et al., (2001) used microneurographic 
recordings to explore relationships between adiposity and SNS function in normotensive black 
and white adults of similar age and BMI.  Sympathetic nervous system activity in black females 
was closely correlated to BMI.  Contrary to the present study, this relationship was also observed 
in their group of white females.  In an obese population regional SNS modulation varies in 
magnitude to various organ systems (Davy & Orr, 2009).  Therefore, the different techniques 
used to assess SNS function between our study and Abate et al. could explain the lack of 
agreement in findings for the white females.   
As previously described, the relationship between MetS, obesity, and SNS overactivation 
is affected by an array of factors deeming this association complex.  Several hypotheses have 
been proposed to explain the over-expression of SNS activity observed in obesity (Straznicky, 
Eikelis, Lambert, & Esler, 2008).  These include (1) leptin concentration, which in obese 
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adolescents has been shown to explain a significant portion of the variance in SO (Guizar, 
Ahuatzin, Amador, Sanchez, & Romer, 2005); (2) IR, which has been shown to cause higher 
SNS activity in obese adolescents when compared to non-IR obese controls (Tascilar, 
Yokusoglu, Boyraz, Baysan, Koz, & Dundaroz, 2011); and (3) OBSA, which has been shown to 
result in higher SNS activity in obese adolescents when compared to obese controls without 
OBSA (Snow, Khalyfa, Serpero, Capdevila, Kim, Buazzo, & Gozal, 2009).  Due to the cross-
sectional nature of the current study, we were only able to make observations regarding 
relationships between possible causative mechanisms for the SO observed in our obese black 
females.  Leptin was not measured in this study and subjects with OBSA were excluded from the 
analysis.  As a measure of IR, HOMA-IR was not related to ERI in either group.  This is in 
disagreement with a previous finding that suggested HOMA-IR was associated with ANS 
dysfunction, as defined by exercise recovery kinetics, in a group of young individuals with a 
wide range of ERI values (9 to 34) (Yeckel et. al., 2009).  It is important to note that in the 
current study, the black females had a significantly higher ERI than their white counterparts.  
However, both groups had higher ERI values than previously reported in a non-obese population, 
thus potentially limiting the ability of HOMA-IR to assess relationships without a larger variance 
in ERI.  
The results within the current study should be taken in consideration of the following 
limitations.  The results of this study support differences in SNS activity between black and 
white obese female adolescents.  However, this finding is supported by a tool that has only been 
validated using an indirect method for assessing SNS function, high-carbohydrate meal-induced 
thermogenesis.  Additionally, this study lacks a normal weight control group to further compare 
ethnic differences.  Lastly, we did not control for menstrual cycle (McKinley et al., 2009) or 
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tanner stage (Tanaka, Borres, Thulesius, Tamai, Ericson, Lindblad, 2000) both of which have 
been shown to impact ANS function.     
In summary, the findings within the scope of the current study demonstrate that black 
obese adolescent females may display higher SNS activity when compared to their white 
counterparts.  It has been postulated that elevated SNS activity in adolescence plays a pivotal 
role in the development of hypertension, CVD, and type II diabetes later in life (Srinivasan, 
Myers, & Berenson, 2001), therefore based on the findings of the current study, black obese 
female adolescents may be at a higher risk for the development of disease later in life.  
Additionally, %FAT and VO2FFM were significant independent predictors of the variance in SNS 
activity in the black females.  Thus, physical training aimed at improving VO2max coupled with 
appropriate dieting may elicit the most favorable changes in ANS function in black adolescent 
obese females.   
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Table 1 Subject characteristics. 
Variable      Black        White 
Age (years)              13.7 ± 1.7    13.3 ± 2.1 
BMI (kg/m
2
)              38.2 ± 6.2    35.1 ± 5.4 
Percent Fat (%FAT)             52.1 ± 4.6    49.9 ± 5.1 
Fitness (VO2Peak [L/min])              2.4 ± 0.4      2.4 ± 0.3 
Fitness (VO2FFM [mL/kg(FFM)/min])          50.0 ± 7.4    54.0 ± 6.4 
Fasting Insulin (μU/mL)            19.1 ± 15.4    16.1 ± 10.9 
HOMA-IR                           4.0 ± 3.4      3.4 ± 2.4 
Fasting TAG (mg/dL)             75.8 ± 28.0*  114.5 ± 56.0 
Total Cholesterol (mg/dL)          155.8 ± 36.7  158.2 ± 30.0 
LDL Cholesterol (mg/dL)          79.72 ± 36.0  92.13 ± 20.3 
HDL Cholesterol (mg/dL)            43.1 ± 12.4          41.67 ± 8.8 
Systolic Blood Pressure (mmHg)         119.2 ± 9.7*          111.0 ± 9.3 
Diastolic Blood Pressure (mmHg)           64.6 ± 5.4              61.9 ± 6.7 
ERI               29.8 ± 6.4*            24.1 ± 3.1 
* P < 0.05, Black vs. White.  Values are mean ± SD.  BMI, Body Mass Index; VO2peak, Maximal 
Oxygen Consumption; VO2FFM, Maximal Oxygen Consumption per kg Fat-Free Mass; HOMA-
IR, Homeostasis Model Assessment for Insulin Resistance; TAG, Triglycerides; LDL, Low 
Density Lipoprotein; HDL, High Density Lipoprotein; ERI, Exercise Recovery Index. 
 
 
 
 
 
 55 
Table 2 Pearson Product-Moment Correlations to ERI 
Variable      Black            White 
Percent Fat (%FAT)     0.275   0.095 
logHOMA-IR               0.162              0.215 
Fasting Insulin (μU/mL)               0.102   0.094 
Fasting TAG (mg/dL)     0.154                0.282 
Systolic Blood Pressure (mmHg)             -0.138   0.204 
Fitness (VO2FFM [mL/kg(FFM)/min])            -0.347*   0.026 
* P < 0.05, Values are Correlation Coefficients (r).  ERI, Exercise Recovery Index; HOMA-IR, 
Homeostasis Model Assessment for Insulin Resistance; TAG, Triglycerides; VO2FFM, Maximal 
Oxygen Consumption per kg Fat-Free Mass 
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Table 3 Multiple Linear-Regression for ERI as the Dependent Variable 
Variable    Standardized      Semi-Partial (r) 
Coefficient (β) 
Black (R
2
 = 0.273, P = 0.037) 
Percent Fat (%FAT)*        0.360                    0.326 
logHOMA-IR                  0.291           0.159 
Fasting Insulin (μU/mL)      -0.134          -0.075 
Fasting TAG (mg/dL)        0.001           0.001 
Systolic Blood Pressure (mmHg)     -0.23          -0.214 
Fitness (VO2FFM [mL/kg(FFM)/min])*  -0.313          -0.310 
White (R
2
 = 0.375, P = 0.788) 
Percent Fat (%FAT)       -0.284                  -0.152 
logHOMA-IR                  1.317           0.353 
Fasting Insulin (μU/mL)     -1.069          -0.278 
Fasting TAG (mg/dL)       0.574           0.364 
Systolic Blood Pressure (mmHg)     0.298           0.204 
Fitness (VO2FFM [mL/kg(FFM)/min])   -0.175          -0.117 
* P < 0.05: ERI, Exercise Recovery Index; HOMA-IR, Homeostasis Model Assessment for 
Insulin Resistance; TAG, Triglycerides; VO2FFM, Maximal Oxygen Consumption per kg Fat-Free 
Mass 
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Figure 1 Exercise Recovery Data between Groups 
 
* P = 0.004; Box plot line is median value, box is divided as upper and lower quartiles. 
 
 
 
 
 
 
 
 
 
 
   * 
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Figure 2 Relationship between ERI and VO2FFM in Black Adolescent Females 
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